Liver International · 2014 · 13 citations · 17 references
Veterinary MedicineImmunologyPathobiologyImmunopathologyInflammationInnate ImmunityAcute InflammationCytokine-mediated PathologyHepatic PathophysiologyLiver DiseaseMetabolic InflammationSystemic Inflammatory ResponseAcute Liver Injury BiomarkersAcute-phase MediatorsAcute-phase ProteinsHepatic Inflammatory InjuryImmune-mediated Hepatic InjuryImmune-mediated Liver InjuryInflammation In Liver InjuryInflammatory Liver Injury
BACKGROUND & AIMS: Patients with non-alcoholic steatohepatitis (NASH) have increased mortality, including from infections. We, therefore, tested in a rodent model of steatohepatitis whether the hepatic acute phase response is intact. METHODS: Steatohepatitis was induced in rats by feeding a high-fat, high-cholesterol diet for 4 (early) and 16 weeks (advanced NASH). 2 h after low-dose LPS (0.5 mg/kg i.p.), we measured the serum concentrations of tumour necrosis factor-α (TNF-α) and interleukin-6 (IL-6). We also measured liver mRNA's and the serum concentrations of acute phase proteins 24 h after LPS. RESULTS: Non-alcoholic steatohepatitis in itself increased the liver mRNA levels of TNF-α and IL-6 and also the liver mRNA and serum levels of the acute phase proteins. The exposure to LPS increased serum TNF-α in both early and advanced NASH and more so than in the control rats. However, the increases in acute phase protein genes in liver tissue and proteins in the blood were lower than in the control rats. CONCLUSION: In rats with early or advanced experimental NASH, LPS despite an increased interleukin release resulted in a blunted acute phase protein response. This tachyphylaxis may be part of the mechanism for the increased infection susceptibility of patients with NASH. We speculate that the steatosis-related interleukin release desensitises the signalling pathway leading to acute phase protein synthesis.
17
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
David E. Kleiner, Elizabeth M. Brunt, Mark L. Van Natta et al. · Hepatology · 2005 · 10.7K citations
Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity☆, ☆☆
Christi A Matteoni, Zobair M. Younossi, T GRAMLICH et al. · Gastroenterology · 1999 · 3.4K citations · Full text
Long‐term follow‐up of patients with NAFLD and elevated liver enzymes†‡
Mattias Ekstedt, Lennart Franzén, Ulrik Mathiesen et al. · Hepatology · 2006 · 2.3K citations
Naga Chalasani, Zobair M. Younossi, Joel E. Lavine et al. · The American Journal of Gastroenterology · 2012 · 590 citations
Induction of rat acute‐phase proteins by interleukin 6 in vivo
Thomas Geiger, Tilo Andus, Jan Klapproth et al. · European Journal of Immunology · 1988 · 409 citations